The application for marketing authorization for the combination was submitted to the FDA in July 2025. …
Tag:
chronic lymphocytic leukemia
-
-
Regular immunoglobulin replacement therapy (IgRT) was not associated with a reduced risk of infection-related hospitalizations in …